REGN

REGN Stockholders Equity

$31.71BQuarterly · USD

Period ending:

REGN FY Shareholders EquityUSD
REGN FY Shareholders Equity1990-12-31: $12.20M1991-12-31: $106.20M1992-12-31: $87.20M1993-12-31: $98.40M1994-12-31: $67.10M1995-12-31: $67.90M1996-12-31: $106.90M1997-12-31: $138.90M1998-12-31: $131.20M1999-12-31: $109.50M2000-12-31: $182.13M2001-12-31: $266.36M2002-12-31: $145.98M2003-12-31: $137.64M2004-12-31: $182.54M2005-12-31: $114.00M2006-12-31: $216.62M2007-12-31: $460.27M2008-12-31: $418.85M2009-12-31: $396.76M2010-12-31: $527.82M2011-12-31: $485.73M2012-12-31: $1.25B2013-12-31: $1.95B2014-12-31: $2.54B2015-12-31: $3.65B2016-12-31: $4.45B2017-12-31: $6.14B2018-12-31: $8.76B2019-12-31: $11.09B2020-12-31: $11.03B2021-12-31: $18.77B2022-12-31: $22.66B2023-12-31: $25.97B2024-12-31: $29.35B2025-12-31: $31.26B$31.26B$0.00
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

REGN stockholders equity history

Net worth of the company (assets minus liabilities). The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Regeneron Pharmaceuticals Stockholders Equity — Annual fiscal periods (USD)
Period endingStockholders Equity (USD)
31,256,900,000
29,353,600,000
25,973,100,000
22,664,000,000
18,768,800,000
11,025,300,000
11,089,700,000
8,757,300,000
6,144,078,000
4,449,245,000
3,654,837,000
2,542,325,000
1,952,076,000
1,245,385,000
485,732,000
527,815,000
396,762,000
418,852,000
460,267,000
216,624,000
114,002,000
182,543,000
137,643,000
145,981,000
266,355,000
182,130,000
109,500,000
131,200,000
138,900,000
106,900,000
67,900,000
67,100,000
98,400,000
87,200,000
106,200,000
12,200,000

Compare stockholders equity

All REGN financial metrics · REGN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.